Dr. Reda Girgis, MD
Claim this profileSpectrum Health
Studies Bronchiolitis Obliterans Syndrome
Studies Syndrome
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
Spectrum Health
Corewell Health
More about Reda Girgis, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Reda Girgis, MD has experience with
- Extracorporeal Photopheresis (ECP)
- Prospera
Breakdown of trials Reda Girgis, MD has run
Bronchiolitis Obliterans Syndrome
Bronchiolitis Obliterans
Lung Transplant Rejection
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Reda Girgis, MD specialize in?
Reda Girgis, MD focuses on Bronchiolitis Obliterans Syndrome and Syndrome. In particular, much of their work with Bronchiolitis Obliterans Syndrome has involved treating patients, or patients who are undergoing treatment.
Is Reda Girgis, MD currently recruiting for clinical trials?
No, Reda Girgis, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Reda Girgis, MD has studied deeply?
Yes, Reda Girgis, MD has studied treatments such as Extracorporeal Photopheresis (ECP), Prospera.
What is the best way to schedule an appointment with Reda Girgis, MD?
Apply for one of the trials that Reda Girgis, MD is conducting.
What is the office address of Reda Girgis, MD?
The office of Reda Girgis, MD is located at: Spectrum Health, Grand Rapids, Michigan 45903 United States. This is the address for their practice at the Spectrum Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.